ENTITY Kanghua Bio

Kanghua Bio

PulseAugur coverage of Kanghua Bio — every cluster mentioning Kanghua Bio across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

1

1 over 90d

TIER MIX · 90D

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

TOOL · CL_59516 · May 29 · 11:44

Kanghua Bio subsidiary begins Phase II trials for RSV mRNA vaccine

Kanghua Bio announced that its subsidiary, Naimi Xin, has initiated Phase II clinical trials for its self-developed lyophilized respiratory syncytial virus (RSV) mRNA vaccine. This development marks a significant step i…